Introduction
Resistance to aminocyclitol aminoglycosides is an important clinical problem since these antibiotics are widely used in the treatment of serious infections.lS2 Amikacin has been the drug of choice for treating nosocomial infections refractory to other aminoglyco~i d e s .~'~ In recent years, resistance to amikacin due to production of 3'-aminoglycoside-phosphotransferases, 2"-adenyltransferases and aminoglycoside-6'-N-acetyltransferases has been r e p~r t e d .~-~ In nosocomial isolates, genes encoding resistance to amikacin most frequently belong to the aac(6')-I group and can be encoded by plasmids or have a chromosomal locus, as is the case with Serratia marce~cens.~~ The frequent presence of genes encoding modifying enzymes in plasmids or transpos~ns,~~ lo and, consequently, their capacity for dispersion, further increases the clinical problems posed by antibiotic resistance. It appears, from studies limited in each case to one institution, that the substitution of another aminoglycoside by amikacin may not necessarily be followed by a concomitant increase in resistance to the antibiotic. According to one study, predominant use of amikacin may result in a general reduction in the number of aminoglycoside-resistant isolate^.^ However, other studies have described a correlation between increased amikacin use and the occurrence of enzyme-mediated resistance in gram-negative bacilli4 In Argentina, as in many hospitals from other non-developed countries, it is very difficult to establish a relationship between clinical observations and the spread of antibiotic resistance because many variables are involved and not all can be controlled appropriately. This study was designed to analyse molecular changes that occurred in association with the emergence of resistance to amikacin over a period of 8 years in nine bacterial species isolated from patients hospitalised in the J. A. Fernandez Hospital of Buenos Aires. The appearance of enzymes, plasmids, sequences related to Tn1331 and the gene responsible for amikacin resistance were investigated.
Materials and methods

Bacterial strains and culture
Escherichia coli HBlOl pro leu thi lacy hsr hsm recAll and E. coli C2 1 1OpolA gyrA12 were provided by BioSidus Laboratory (Buenos Aires), and were used in this study as recipients in transformation and conjugation experiments, respectively. One hundred and twenty-seven gram-negative clinical isolates, comprising 49 amikacin-resistant (AR) S. Isolates were identified by standard methods.13 All AR isolates selected for the study were resistant to five or more antibiotics, including amikacin, and were isolated from patients with nosocomial infection, i.e., patients who had been hospitalised for at least 2 days before a sample revealed a positive bacterial culture. The symptoms of infection began at the hospital and were not present prior to admission. These isolates were grown in L-broth (Sigma) supplemented with amikacin 20 mg/L.
Antimicrobial susceptibility tests
Antibiotic resistance was investigated by the disk diffusion method14 in Mueller-Hinton Agar (Oxoid), (3' )-VIa were prepared as described elsewhere.** lo* 17* The intragenic probe of the Tn1332 transposase was a 2616-bp EcoRV DNA fragment obtained from pJHCMW1.1° A second probe specific for Tn1331 comprised a 3-0-kb BamHI DNA fragment obtained from pJHCMW1.l' All fragments were isolated by electro-elution from agarose gels. Probes were labelled by the random-primer technique with 32P dCTP.'l All hybridisation experiments were performed under maximum stringent conditions as described previously.21 Dot-blot hybridisation experiments were performed by a standard procedure, as described elsewhere. 21 
Results
Incidence of amikacin resistance
Amikacin resistance increased steadily in several species throughout the study. From 1982 to the present time, amikacin has been used as the aminoglycoside of second choice, except in 1985 when it was selected as the aminoglycoside of first choice while gentamicin became the second choice. Resistance to gentamicin was a clinical problem during the study (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) . The frequency of gentamicin-resistant isolates in different species was 60-70Y0 in Klebsiella spp., 55-65 YO in Ent. cloacae, 90 YO in S. marcescens, 65 YO in C. freundii and 75-85 YO in Acinetobacter spp. These frequencies remained high throughout the study. Table I1 summarises data on the incidence of amikacin resistance in Enterobacteriaceae and Acinetobacter spp. There was a 2-4-fold increase in the prevalence of amikacin resistance in isolates of Ent. cloacae, Klebsiella spp. and Acinetobacter spp., between 1984 and 1991 with a baseline of 2 10% in 1984. Among E. coli, Proteus spp. and C. freundii isolates, the average percentages of amikacin resistance were 2, 6 and 12 YO, respectively, and remained relatively constant throughout the study (8 years). Resistance to amikacin in S. typhimurium appeared in a few isolates (< 1 YO) in 1990. Rates of amikacin resistance in E. coli, Proteus spp., C. freundii and S. typhimurium did not differ significantly from those described in other hospitals from this country (table  11) . Rates of amikacin resistance in S. marcescens were the highest when compared with those from other species in 1984 (42%) and reached 70% in 1986. It should be noted that the incidence of resistance to amikacin in Klebsiella spp. and Acinetobacter spp. increased steadily throughout the study, and was higher overall than in S. marcescens.
Genes involved in amikacin resistance
A total of 127 clinical isolates from patients with nosocomial infection was selected in this period for further investigation. These isolates were resistant to five or more common antibiotics, including amikacin. Although it was not considered a selection criterion, 90 YO of the isolates were also resistant to gentamicin. The genes encoding amikacin resistance found in this study are summarised in table 111. The presence of enzymes belonging to the AAC(6')-I class is characterised by resistance to tobramycin, dibekacin, amikacin, 5'-episisomicin, netilmicin, 2'-ethylnetilmicin and sisomicin. At least six genes encoding this AGRP have been identified. 6 We analysed the bacterial population with probes currently available for the aac(6')-Ia, aac(6)-Ib and aac(6)-Ic genes. The frequency of these genes varied among the different species investigated and the aac(6)-Ia gene was never found in 10 Acinetobacter isolates, 17 K. pneumoniae, two E. coli and 10 S. marcescens isolates. The aac(6)-Ic gene was detected by dot-blot hybridisation in every S. marcescens isolate and was the only amikacin resistance marker in 72 YO of these isolates. The aac(6)-Ib gene was found in five S. marcescens, one E. coli, one Ent. cloacae, 13 K. pneumoniae, one K. oxytoca, two C. freundii, two Proteus spp. and two S. typhimurium isolates. Excluding Serratia and Acineto- AGRPs causes the phenotype of resistance to gentamicin, tobramycin, netilmicin and amikacin, which were all aminoglycosides marketed in Argentina at the time of the study.
Ten Acinetobacter isolates expressing the AAC(6')-I AGRP failed to hybridise with any of the three probes described above (table 111) . Therefore, a 2700-bp Hind111 DNA fragment was cloned in pUC 18 from a 15.5-kb acinetobacter plasmid. This fragment was able to encode the AAC(6')-1 activity in E. coli HB101. Dot-blot hybridisation with this fragment as probe against 71 Enterobacteriaceae and 10 Acinetobacter isolates expressing the AAC(6')-I AGRP showed that only the Acinetobacter isolates hybridised with the probe. The fact that 71 Enterobacteriaceae, plus 20 other Acinetobacter isolates not expressing the AAC(6')-1 activity, did not hybridise with the 2700-bp fragment demonstrated that the newly developed probe was specific enough for the purposes of this study. In Acinetobacter spp. the AAC(6')-I pattern occurred in combination with the AAC(3)-1 AGRP.
The APH(3')-VI AGRP is associated with resistance to kanamycin, neomycin, paromomycin, ribostamycin, butirosin, gentamicin B, amikacin and isepamicin. It is known that there are at least two genes that encode this AGRP. (6) 
Characterisation of arnikacin resistance plasmids
The occurrence of plasmids conferring resistance to amikacin in 42 AR isolates was investigated by conjugation with E. coli C2110 or transformation of E. coli HB101, or both. These isolates included all Enterobacteriaceae that had hybridised with the aac(6)-Ib, or aph(3')-VIa genes. Ten Acinetobacter isolates were also tested but did not transfer any plasmid to E. coli C2110; transformation of E. coli with acinetobacter plasmids is, however, a rare event.23* 24 The aac(6')-Ib gene was transferred, by transformation, from one E. coli, two Proteus spp., two C. freundii, one Ent. cloacae, five S. rnarcescens, 13 K . pneurnoniae, one K. oxytoca and two S. typhirnuriurn isolates to E. coli HB101. Amikacin resistance was associated with the presence of plasmid DNA between 10 and 20 kb in size. Five of these plasmids were mobilised in conjugation experiments with E. coli C2110. The plasmids recovered from transconjugants or transformants conferred resistance not only to amikacin, but also to tobramycin, streptomycin and ampicillin, and yielded 27 different restriction endonuclease fragment patterns after BarnHI digestion. Digestion of all 27 plasmids with BarnHI generated a 3000-bp fragment that hybridised with the aac(6')-Ib gene probe.
Plasmid DNA samples from one E. coli, four K. pneurnoniae, one Ent. cloacae and nine S. rnarcescens isolates that carried the aph(3')-VIa gene were all conjugative and all transferred resistance to amikacin and ampicillin. Twelve different plasmids, with sizes from 20 to 60 kb, were found in these 15 strains. One of these plasmids (35 kb) was found in four different isolates. These four plasmids carried the aph(3')-VIa gene in a 4-7-kb BamHI DNA fragment. One plasmid, from an E. coli isolate, also encoded resistance to cefotaxime and cefoxitin. The aac(6)-Ib and aph(3')-VIa genes, present in a single strain of K. pneumoniae, were located to two different plasmids.
SstI and hybridised with a 3-kb BamHI DNA fragment specific for Tn1331. The results revealed that 26 of the plasmids exhibited a hybridisation pattern indicative of transposon Tn1331 (figure). Plasmid pDCECL2 from one Ent. cloacae isolate, for example, exhibited a hybridisation pattern similar to that of P D C S P~~~ carrying Tn1331 (figure). Plasmid DNA from all 27
Presence of DNA sequences related to Tn1331 isolates digested with EcoRV and hybridised against the intragenic probe of the Tn1331 transposase Dot-blot analysis of the 127 amikacin-resistant revealed that 26 plasmids hybridised in the 2-6-kb isolates with an intragenic probe of the Tn1331
EcoRV DNA fragment. Plasmid DNA from E. coli transposase revealed that only those bearing the isolate 67 (EC67) hybridised in a 2.0-kb EcoRV DNA aac(6')-Ib gene hybridised with the probe. Plasmid fragment. Plasmid DNA from EC67 (pDCEC67) DNA from the 27 transformants carrying the aac(6)-exhibited a different Tn1331 hybridisation pattern, Ib gene was digested with BamHI, BglI and EcoRV/ although the plasmid shared certain homology in different fragments (figure). In spite of these differences, pDCEC67 had a 3.0-kb BamHI DNA fragment similar to that exhibited by Tn1331. To analyse sequences adjacent to the aac(6')-Ib gene, the 3.0-kb BamHI fragment of PDCEC67 was cloned into pUC 18. Restriction endonuclease analysis with BamHIIAvaI, BamHIIXhoI and BamHIIKpnI demonstrated that this recombinant plasmid had similar, if not identical, aac(6')-Ib sequences adjacent to Tn1331 (data not shown). Finally, although conditions for hybridisation were the same in both cases, undigested plasmid pDCECL2 hybridised with the 3.0-kb Tn1331 probe (figure, top panel, lane 9) but failed to hybridise with the 2616-bp probe (figure, bottom panel, lane 4), probably due to the low efficiency of undigested plasmid transference.21 However, digested pDCECL2 DNA hybridised with both probes, which permitted us to reach the conclusions presented here.
Discussion
A previous report has shown that the APH(3')-VI AGRP is associated primarily with Acinetobacter spp. (35.4%) and was rarely observed in the other gramnegative bacteria.6 At least two genes have been identified that encode this AGRP, aph(3')-VIa and aph(3')-VIb.6y Amikacin resistance in strains of Acinetobacter spp. isolated from nosocomial infections was related to the presence of the aph(3')-VIa gene.24 This gene has also been shown to be carried by Tn1528 in a Providencia stuartii isolate. 26 The aph(3')-VIb gene was cloned from the K. pneumoniae plasmid pRPGlOl 27 but DNA hybridisation studies were not performed to show the relationship between this gene and the aph(3')-VIa from Acinetobacter ~p p .~ Surprisingly, in this study with Enterobacteriaceae, aph(3')-VIa, a gene confined so far to Acinetobacter spp., was also found in plasmids of S. marcescens, K. pneumoniae, Ent. cloacae and E. coli (20%). In the remaining SO%, as expected, the AAC(6')-I AGRP was responsible for resistance to amikacin. Two genes were found in the Enterobacteriaceae population encoding this AGRP. These were the aac(6')-Ib and the aac(6')-Ic genes.8' 28 The former was described previously in plasmid DNA from K. pneumoniae, E. coli and S. marces~ens.~* 28-30 This gene was also found in plasmid DNA from Proteus spp., S . typhimuriurn, Ent. cloacae, K. oxytoca and C. freundii. The latter gene was found in 72 YO of S. marcescens isolates as the sole mechanism of resistance to amikacin. The only gene consistently found in both Acinetobacter spp. and Enterobacteriaceae was aph(3')-VIa. Furthermore, one K. pneumoniae isolate harboured two R-plasmids, one carrying the aph(3')-VIa and the other the aac(6')-Ib gene. The species that harboured the highest number of gene types conferring amikacin resistance was S. marcescens, which carried aac(6')-Ib, aac(6')-Ic and aph(3')-VIa genes.
DNA from 20% of those Acinetobacter isolates expressing the AAC(6')-I AGRP did not hybridise with aac(6')-Ia, aac(6')-Ib or aac(6')-Ic probes. Preliminary cloning studies from this laboratory revealed that this activity was located in a 15.5-kb plasmid from an Acinetobacter sp. A probe developed from this plasmid hybridised with those Acinetobacter isolates, whereas none of the Enterobacteriaceae isolates hybridised with this probe. This may represent the finding of a new gene, or another amongst other genes that have been reported recently, after this study was 319 32 Further studies are required to identify and characterise this gene. Although resistance to gentamicin was not used as a criterion for selecting AR strains, AAC(3)-V, ANT(2")-1 and AAC(3)-1 AGRPs were found in 90 YO of the isolates, in combination with other mechanisms. The gentamicin-tobramycin-netilmicin-amikacin (the sole aminoglycosides marketed in Argentina during the study) phenotype was common in this survey because of the high incidence ( 5 5 % ) of isolates with the combination of AAC(3)-V with APH(3')-VI or AAC(6')-I AGRPs, or both. These combinations were found more frequently in our survey than in a survey reported by others.6 It should be noted that in our bacterial population the combination of AAC(3)-V with APH(3')-VI or AAC(6')-I AGRPs, or both, was not located on broad host range plasmids because the aac(6')-Ib and the aph(3')-VIa genes were always found in plasmids that did not transfer the gentamicin resistance.
The frequency of nosocomial infections due to AR gram-negative bacilli was documented in the USA in 1985 and the rates ranged from 0-8 to 3~5 % .~-~ The rates found in Argentina33 are remarkably higher than those found in the USA and E~r~p e .~~~~ Because, surprisingly, high rates of aminoglycoside resistance are found in isolates from most hospitals in Argentina, extreme care is routinely taken when assessing antimicrobial susceptibility. All isolates in this study were investigated by both disk diffusion and agar dilution tests and quality control was performed as recommended by NCCLS. 15 The fact that not only in our hospital, but also in other hospitals in Argentina,33 similar high rates of AR gram-negative bacilli have been found, lends credibility to our unusual findings and led us to design the present study. Thirty-one percent of all S. marcescens and 15% of all Acinetobacter and Klebsiella isolates from patients suffering from nosocomial infections in our hospital were resistant to amikacin in 1985. These resistance rates were not uniform and a steady increase in amikacin resistance was observed following modifications in aminoglycoside usage, although there is no proof that a cause-effect phenomenon has taken place. When aminoglycoside resistance mechanisms were investigated, it was seen that an unusually high number of isolates carried the combination of AAC(3)-V or AAC(3)-I with AAC(6')-I or APH(3')-VI AGRPs, which conferred resistance to both amikacin and gen-tamicin. The species that carried the aph(3')-VIa gene with a frequency higher than that reported previously by others,6 were the ones usually involved in nosocomial infections and exhibited high rates of amikacin resistance. Ecological factors such as poor environmental control, which favour spreading of R-plasmids, may have also contributed to the maintenance of amikacin resistance. It is interesting to note that AAC(6')-I group enzymes are capable of inactivating amikacin but only cause resistance, according to the standards set by NCCLS, when the enzymic activity is expressed at high levels. Therefore, it is important to decide, according to the design of the study, the precise cut-off to determine which specimens would be considered. Because only isolates with an MIC > 16 mg/L were included in this study, the high percentage of those expressing the APH(3')-VI AGRP is not an artifact, due to missing specimens bearing AAC (6')-I, but a true estimate of the incidence of APH(3')-VI AGRP.
Previous reports have shown that outbreaks due to amikacin-resistant Enterobacteriaceae usually involve single plasmid species carrying the aac(6')-I 29 Hopkins et al. described four plasmids from 21 Enterobacteriaceae isolate^.^ For another aminoglycoside gene, the same epidemic plasmid was found w o r l d~i d e .~~ Enterobacteriaceae described in this report harboured at least 42 plasmid species mediating the aac(6')-lb or the aph(3')-VIa genes; 48 YO of these plasmids were conjugative, which indicates conjugation as a likely mechanism mediating the spread of ami kacin resistance.
Different aac(6')-I genes may be found in transposons of the Tn3 family.5,9.10 More recent data have suggested that Tn21 contains a specific region, the integron, into which many different resistance genes may be i n~e r t e d .~,~~ In the light of this information, dissemination of these transposons was investigated in all AR isolates. Hybridisation strategies were used for this purpose, including an intragenic probe of the Tn1331 transposase that has a nucleotide sequence identical to that of Tn3 and Tn21.l' In this study we identified Tn1331-related sequences solely in plasmids harbouring the aac(6')-Zb gene. This gene was found in all 27 plasmids in a 3-0-kb BamHI fragment. Cloning and restriction analysis of this BamHI fragment with four endonucleases revealed that sequences adjacent to the aac(6')-Ib gene were identical in pDCEC67, a plasmid that displayed other genetic dissimilarities at the level of the Tn1331 transposase gene. Conversely, in a study that described four plasmids carrying Tn3-related transposons from 2 1 nosocomial outbreak isolates, Hopkins et al. showed that sequences adjacent to aac(d')-I alleles were different.5 Because all plasmids were different by restriction endonuclease analysis, several possible sources for Tn1331 are suggested : (i) the dissemination of Tn1331 may have been due to transposition mechanisms which occurred after intraor inter-species transference; (ii) after transfer of a plasmid carrying Tn1331, a process of plasmid recombination may have been responsible for the appearance of Tn1331 in different plasmids; (iii) although unlikely, all isolates carrying different plasmids may have originated from different infection sources; or (iv) a combination of these mechanisms. Because the rate of AR isolates varied within each species in spite of the presence of Tn1331, it is concluded that this transposon may not be the sole factor responsible for the observed variation.
